サンプル依頼リスト カート
  • English
  • Korean
  • Traditional Chinese
  • Simplified Chinese
デフォルト表紙
市場調査レポート
商品コード
1504935

世界の希少疾患診断市場、シェア、規模、動向、産業分析レポート：疾病タイプ別、製品タイプ別、サンプルタイプ別、技術別、テスト別、年齢層別、特性タイプ別、エンドユーザー別、地域別、セグメント予測、2024年-2032年

Global Rare Disease Diagnostics Market Share, Size, Trends, Industry Analysis Report, By Disease Type; By Product Type; By Sample Type; By Technology; By Test; By Age Group; By Trait Type; By End-User; By Region; Segment Forecast, 2024 - 2032

出版日
ページ情報
英文 118 Pages
納期
即日から翌営業日
カスタマイズ可能
価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=157.50円
世界の希少疾患診断市場、シェア、規模、動向、産業分析レポート：疾病タイプ別、製品タイプ別、サンプルタイプ別、技術別、テスト別、年齢層別、特性タイプ別、エンドユーザー別、地域別、セグメント予測、2024年-2032年
出版日: 2024年05月01日
発行: Polaris Market Research
ページ情報: 英文 118 Pages
納期: 即日から翌営業日
  • 全表示
  • 概要
  • 図表
  • 目次
概要

Polaris Market Research社の最新調査によると、世界の希少疾患診断市場規模は2032年までに889億6,927万米ドルに達する見込みです。この調査レポートは、現在の市場力学を詳細に洞察し、将来の市場成長に関する分析を提供しています。

希少疾患診断市場は、急速な技術進歩と規模の経済によって促進されるゲノムシークエンシングの入手しやすさと価格の上昇という技術革新に牽引され、力強い成長を遂げています。シークエンシングのコストが低下し続け、解析速度が向上するにつれて、ゲノム検査はより広く利用できるようになり、ヘルスケアプロバイダーは希少疾患が疑われる患者に包括的な遺伝子評価を提供できるようになりました。

しかし、そのためには、希少疾患の特定に特化した新たな検査法、バイオマーカー、技術の発見と検証が必要です。研究開発への投資は技術革新を促進し、より正確で効率的、かつ費用対効果の高い検査ソリューションの開発を可能にします。学術界、製薬会社、バイオテクノロジー企業の協力は、科学的理解を進め、発見を実用的な診断ツールに変換する上で極めて重要です。

希少疾患を対象とした治療や診断ツールの市場規模が限られていることも、高コストの一因となっています。ヘルスケア団体、政策立案者、医療利害関係者は、希少疾患の経済的負担に対する認識を高め、罹患者のための安価な診断検査や治療へのアクセスを改善するための対策を実施するよう努めています。さらに、技術の進歩や共同研究イニシアチブは、将来的に希少疾患診断のコスト削減と効率化につながることが期待されています。

世界の希少疾患診断市場レポートハイライト

血液・腫瘍疾患分野は、希少な血液疾患や腫瘍疾患を正確かつ迅速に検出し、早期介入やオーダーメイドの治療アプローチにつなげていることから、市場を独占しています。

キット・試薬部門は、迅速かつ正確な診断を可能にする希少疾患の検出技術の進歩により、市場を席巻し、最も速いCAGRで成長すると予測されています。

市場セグメンテーションは、最先端のインフラ、先端技術、診断のための熟練した人材によって市場を独占しています。

希少疾病を正確に特定・診断できる専門的な診断サービスに対する需要の高まりにより、診断ラボ部門は予想される期間で最も高いCAGRを示すと予想されます。

北米は、希少疾患の診断と治療に重要な役割を果たす遺伝子検査と精密医療の進歩により、業界をリードし、市場収益シェアの大半を占めています。

目次

第1章 イントロダクション

第2章 利害関係者

第3章 エグゼクティブサマリー

第4章 調査手法

第5章 世界の希少疾患診断市場の洞察

  • 希少疾患診断-業界スナップショット
  • 希少疾患診断市場力学
    • 促進要因と機会
      • ゲノム技術の進歩が診断の革新を推進
      • 認知度の向上により診断の需要が高まる
    • 抑制要因と課題
      • 高いコスト
  • PESTEL分析
  • 希少疾患診断業界
  • バリューチェーン分析
  • COVID-19の影響分析

第6章 世界の希少疾患診断市場：疾病タイプ別

  • 主な調査結果
  • イントロダクション
  • 消化器疾患
  • 内分泌および代謝障害
  • 心血管疾患
  • 筋骨格障害
  • 神経疾患
  • 血液学および腫瘍学疾患
  • 皮膚科疾患
  • その他

第7章 世界の希少疾患診断市場：製品タイプ別

  • 主な調査結果
  • イントロダクション
  • キットと試薬
  • 機器
  • ソフトウェア

第8章 世界の希少疾患診断市場：サンプルタイプ別

  • 主な調査結果
  • イントロダクション
  • 血液サンプル
  • 頬粘膜スワブサンプル
  • その他

第9章 世界の希少疾患診断市場：技術別

  • 主な調査結果
  • イントロダクション
  • 次世代シーケンシング
  • 全エクソーム
  • 全ゲノム
  • アレイテクノロジー
  • PCRベースの検査
  • FISH
  • サンガーシーケンス
  • 核型分析

第10章 世界の希少疾患診断市場：検査別

  • 主な調査結果
  • イントロダクション
  • 遺伝子検査
  • 一般的な臨床検査
  • 画像検査

第11章 世界の希少疾患診断市場： 年齢層別

  • 主な調査結果
  • イントロダクション
  • 大人
  • 子供

第12章 世界の希少疾患診断市場：特性タイプ別

  • 主な調査結果
  • イントロダクション
  • 遺伝性
  • 後天性

第13章 世界の希少疾患診断市場：最終用途別

  • 主な調査結果
  • イントロダクション
  • 調査機関とCRO
  • 病院・クリニック
  • 診断検査室

第14章 世界の希少疾患診断市場：地域

  • 主な調査結果
  • イントロダクション
    • 希少疾患診断市場評価：地域、2019年～2032年
  • 北米
    • 北米：疾病タイプ別、2019年～2032年
    • 北米：技術別、2019年～2032年
    • 北米：製品タイプ別、2019年～2032年
    • 北米：テスト別、2019年～2032年
    • 北米：サンプルタイプ別、2019年～2032年
    • 北米：年齢層別、2019年～2032年
    • 北米：特性タイプ別、2019年～2032年
    • 米国
    • カナダ
  • 欧州
    • 欧州：疾病タイプ別、2019年～2032年
    • 欧州：技術別、2019年～2032年
    • 欧州：製品タイプ別、2019年～2032年
    • 欧州：テスト別、2019年～2032年
    • 欧州：サンプルタイプ別、2019年～2032年
    • 欧州：年齢層別、2019年～2032年
    • 欧州：特性タイプ別、2019年～2032年
    • 英国
    • フランス
    • ドイツ
    • イタリア
    • スペイン
    • オランダ
    • ロシア
  • アジア太平洋地域
    • アジア太平洋地域：疾病タイプ別、2019年～2032年
    • アジア太平洋：技術別、2019年～2032年
    • アジア太平洋：製品タイプ別、2019年～2032年
    • アジア太平洋地域：テスト別、2019年～2032年
    • アジア太平洋地域：サンプルタイプ別、2019年～2032年
    • アジア太平洋地域：年齢層別、2019年～2032年
    • アジア太平洋地域：特性タイプ別、2019年～2032年
    • 中国
    • インド
    • 日本
    • マレーシア
    • インドネシア
    • 韓国
  • 中東・アフリカ
    • 中東およびアフリカ：疾病タイプ別、2019年～2032年
    • 中東・アフリカ：技術別、2019年～2032年
    • 中東およびアフリカ：製品タイプ別、2019年～2032年
    • 中東およびアフリカ：テスト別、2019年～2032年
    • 中東およびアフリカ：サンプルタイプ別、2019年～2032年
    • 中東・アフリカ：年齢層別、2019年～2032年
    • 中東およびアフリカ：特性タイプ別、2019年～2032年
    • サウジアラビア
    • アラブ首長国連邦
    • イスラエル
    • 南アフリカ
  • ラテンアメリカ
    • ラテンアメリカ：疾病タイプ別、2019年～2032年
    • ラテンアメリカ：技術別、2019年～2032年
    • ラテンアメリカ：製品タイプ別、2019年～2032年
    • ラテンアメリカ：テスト別、2019年～2032年
    • ラテンアメリカ：サンプルタイプ別、2019年～2032年
    • ラテンアメリカ：年齢層別、2019年～2032年
    • ラテンアメリカ：特性タイプ別、2019年～2032年
    • メキシコ
    • ブラジル
    • アルゼンチン

第15章 競合情勢

  • 拡大と買収の分析
    • 拡大
    • 買収
  • 提携/協業/合意/公開

第16章 企業プロファイル

  • 3billion, Inc.
  • Agilent Technologies, Inc
  • CENTOGENE N.V
  • F. Hoffmann-La Roche Ltd
  • FDNA（TM）INC
  • GeneDx, LLC
  • Illumina, Inc.
  • Invitae Corporation
  • Novo Nordisk A/S
  • Quest Diagnostics
図表

List of Tables

  • Table 1 Global Rare Disease Diagnostics Market, by Disease Type, by Region, 2019-2032 (USD Million)
  • Table 2 Global Rare Disease Diagnostics Market, by Technology, by Region, 2019-2032 (USD Million)
  • Table 3 Global Rare Disease Diagnostics Market, by Mode of Product Type, by Region, 2019-2032 (USD Million)
  • Table 4 Global Rare Disease Diagnostics Market, by Test, by Region, 2019-2032 (USD Million)
  • Table 5 Global Rare Disease Diagnostics Market, by Sample Type, by Region, 2019-2032 (USD Million)
  • Table 6 Global Rare Disease Diagnostics Market, by Age Group, by Region, 2019-2032 (USD Million)
  • Table 7 Global Rare Disease Diagnostics Market, by Trait Type, by Region, 2019-2032 (USD Million)
  • Table 8 Rare Disease Diagnostics Market Assessment, By Geography, 2019-2032 (USD Million)
  • Table 9 North America: Rare Disease Diagnostics Market, by Disease Type, 2019-2032 (USD Million)
  • Table 10 North America: Rare Disease Diagnostics Market, by Technology, 2019-2032 (USD Million)
  • Table 11 North America: Rare Disease Diagnostics Market, by Mode of Product Type, 2019-2032 (USD Million)
  • Table 12 North America: Rare Disease Diagnostics Market, by Test, 2019-2032 (USD Million)
  • Table 13 North America: Rare Disease Diagnostics Market, by Sample Type, 2019-2032 (USD Million)
  • Table 14 North America: Rare Disease Diagnostics Market, by Age Group, 2019-2032 (USD Million)
  • Table 15 North America: Rare Disease Diagnostics Market, by Trait Type, 2019-2032 (USD Million)
  • Table 16 U.S.: Rare Disease Diagnostics Market, by Disease Type, 2019-2032 (USD Million)
  • Table 17 U.S.: Rare Disease Diagnostics Market, by Technology, 2019-2032 (USD Million)
  • Table 18 U.S.: Rare Disease Diagnostics Market, by Mode of Product Type, 2019-2032 (USD Million)
目次
Product Code: PM4902

The global rare disease diagnostics market size is expected to reach USD 88,969.27 million by 2032, according to a new study by Polaris Market Research. The report "Global Rare Disease Diagnostics Market Share, Size, Trends, Industry Analysis Report, By Disease Type; By Product Type; By Sample Type; By Technology; By Test; By Age Group; By Trait Type; By End-User; By Region; Segment Forecast, 2024- 2032" gives a detailed insight into current market dynamics and provides analysis on future market growth.

The rare disease diagnostics market is experiencing robust growth, driven by innovation is the increasing accessibility and affordability of genomic sequencing, facilitated by rapid technological advancements and economies of scale. As the cost of sequencing continues to decline and the speed of analysis improves, genomic testing has become more widely available, enabling healthcare providers to offer comprehensive genetic evaluations to patients with suspected rare diseases.

However, this involves the discovery and validation of novel testing methods, biomarkers, and technologies tailored for identifying rare diseases. Investments in R&D drive innovation, enabling the development of more accurate, efficient, and cost-effective testing solutions. Collaboration between academia, pharmaceutical companies, and biotech firms is crucial in advancing scientific understanding and translating discoveries into practical diagnostic tools.

The limited market size for treatments and diagnostic tools targeting rare diseases also contributes to their high cost. Advocacy organizations, policymakers, and healthcare stakeholders are working to raise awareness of the economic burden of rare diseases and implement measures to improve access to affordable diagnostic testing and treatments for affected individuals. Additionally, advancements in technology and collaborative research initiatives hold promise for driving down costs and improving the efficiency of rare disease diagnosis in the future.

Global Rare Disease Diagnostics Market Report Highlights

The Hematology and Oncology disease segment dominated the market owing to the precise and prompt detection of rare blood and oncological conditions, which led to early intervention and tailored treatment approaches.

The Kits and Reagents segment dominated and is anticipated to grow at the fastest CAGR owing to advancements in the detection of rare diseases, which enable quicker and more precise diagnosis.

The Research Laboratories and Cros segment dominated the market owing to cutting-edge infrastructure, advanced technologies, and skilled personnel for diagnostic purposes.

The Diagnostics Laboratories segment is expected to witness the highest CAGR over the anticipated period due to a rise in demand for specialized diagnostic services that can accurately identify and diagnose rare diseases.

North America led the industry and accounted for a majority of market revenue share owing to the progress made in genetic testing and precision medicine, which play crucial roles in diagnosing and treating rare conditions.

The global key market players include CENTOGENE N.V., F. Hoffmann-La Roche Ltd., FDNA(TM) INC, GeneDx, LLC, Illumina, Inc., Invitae Corporation, Novo Nordisk A/S, Quest Diagnostics, etc.

Polaris Market Research has segmented the global rare disease diagnostics market report based on disease type, product type, sample type, technology, test, age group, trait type, end-user, and region:

Global Rare Disease Diagnostics, Disease Type Outlook (Revenue - USD Million, 2019 - 2032)

  • Gastroenterology Disease
  • Endocrine and Metabolism Disorders Disease
  • Cardiovascular Disorders
  • Musculoskeletal Disorders
  • Neurology Disease
  • Hematology and Oncology Disease
  • Dermatology Disease
  • Others

Global Rare Disease Diagnostics, Product Type Outlook (Revenue - USD Million, 2019 - 2032)

  • Kits & Reagents
  • Instruments
  • Software

Global Rare Disease Diagnostics, Sample Type Outlook (Revenue - USD Million, 2019 - 2032)

  • Blood Sample
  • Buccal Swab Sample
  • Others

Global Rare Disease Diagnostics, Technology Outlook (Revenue - USD Billion, 2019 - 2032)

  • Next Generation Sequencing
  • Whole Exome
  • Whole Genome
  • Array Technology
  • PCR Based Testing
  • FISH
  • Sanger Sequencing
  • Karyotyping

Global Rare Disease Diagnostics, Test Outlook (Revenue - USD Million, 2019 - 2032)

  • Genetic Test
  • General Lab Test
  • Imaging Test

Global Rare Disease Diagnostics, Age Group Outlook (Revenue - USD Million, 2019 - 2032)

  • Children
  • Adult

Global Rare Disease Diagnostics, Trait Type Outlook (Revenue - USD Million, 2019 - 2032)

  • Inherited
  • Acquired

Global Rare Disease Diagnostics, End- Use Outlook (Revenue - USD Million, 2019 - 2032)

  • Research Laboratories & Cros
  • Hospitals & Clinics
  • Diagnostic Laboratories

Global Rare Disease Diagnostics, Regional Outlook (Revenue - USD Million, 2019 - 2032)

  • North America
  • U.S.
  • Canada
  • Europe
  • Germany
  • UK
  • France
  • Italy
  • Spain
  • Russia
  • Netherlands
  • Rest of Europe
  • Asia Pacific
  • China
  • India
  • Japan
  • South Korea
  • Indonesia
  • Australia
  • Malaysia
  • Rest of Asia Pacific
  • Latin America
  • Argentina
  • Brazil
  • Mexico
  • Rest of Latin America
  • Middle East & Africa
  • UAE
  • Saudi Arabia
  • Israel
  • South Africa
  • Rest of Middle East & Africa

Table of Contents

1. Introduction

  • 1.1. Report Description
    • 1.1.1. Objectives of the Study
    • 1.1.2. Market Scope
    • 1.1.3. Assumptions

2. Stakeholders

3. Executive Summary

  • 3.1. Market Highlights

4. Research Methodology

  • 4.1. Overview
    • 4.1.1. Data Mining
  • 4.2. Data Sources
    • 4.2.1. Primary Sources
    • 4.2.2. Secondary Sources

5. Global Rare Disease Diagnostics Market Insights

  • 5.1. Rare Disease Diagnostics - Industry Snapshot
  • 5.2. Rare Disease Diagnostics Market Dynamics
    • 5.2.1. Drivers and Opportunities
      • 5.2.1.1. Advances in genomic technologies drive diagnostic innovation
      • 5.2.1.2. Increasing awareness leads to higher demand for diagnostics
    • 5.2.2. Restraints and Challenges
      • 5.2.2.1. High costs
    • 5.2.3. Porter's Five Forces Analysis
      • 5.2.3.1. Bargaining Power of Suppliers (Moderate)
      • 5.2.3.2. Threats of New Entrants (Low)
      • 5.2.3.3. Bargaining Power of Buyers (Moderate)
      • 5.2.3.4. Threat of Substitute (Moderate)
      • 5.2.3.5. Rivalry among Existing Firms (High)
  • 5.3. PESTEL Analysis
  • 5.4. Rare Disease Diagnostics Industry
  • 5.5. Value Chain Analysis
  • 5.6. COVID-19 Impact Analysis

6. Global Rare Disease Diagnostics Market, by Disease Type

  • 6.1. Key Findings
  • 6.2. Introduction
    • 6.2.1. Global Rare Disease Diagnostics Market, by Disease Type, 2019-2032 (USD Million)
  • 6.3. Gastroenterology Disease
    • 6.3.1. Global Rare Disease Diagnostics Market, by Gastroenterology Disease, by Region, 2019-2032 (USD Million)
  • 6.4. Endocrine and Metabolism Disorders Disease
    • 6.4.1. Global Rare Disease Diagnostics Market, by Endocrine and Metabolism Disorders Disease, by Region, 2019-2032 (USD Million)
  • 6.5. Cardiovascular Disorders
    • 6.5.1. Global Rare Disease Diagnostics Market, by Cardiovascular Disorders, by Region, 2019-2032 (USD Million)
  • 6.6. Musculoskeletal Disorders
    • 6.6.1. Global Rare Disease Diagnostics Market, by Musculoskeletal Disorders, by Region, 2019-2032 (USD Million)
  • 6.7. Neurology Disease
    • 6.7.1. Global Rare Disease Diagnostics Market, by Neurology Disease, by Region, 2019-2032 (USD Million)
  • 6.8. Hematology and Oncology Disease
    • 6.8.1. Global Rare Disease Diagnostics Market, by Hematology and Oncology Disease, by Region, 2019-2032 (USD Million)
  • 6.9. Dermatology Disease
    • 6.9.1. Global Rare Disease Diagnostics Market, by Dermatology Disease, by Region, 2019-2032 (USD Million)
  • 6.10. Others
    • 6.10.1. Global Rare Disease Diagnostics Market, by Others, by Region, 2019-2032 (USD Million)

7. Global Rare Disease Diagnostics Market, by Mode of Product Type

  • 7.1. Key Findings
  • 7.2. Introduction
    • 7.2.1. Global Rare Disease Diagnostics Market, by Mode of Product Type, 2019-2032 (USD Million)
  • 7.3. Kits & Reagents
    • 7.3.1. Global Rare Disease Diagnostics Market, by Kits & Reagents, by Region, 2019-2032 (USD Million)
  • 7.4. Instruments
    • 7.4.1. Global Rare Disease Diagnostics Market, by Instruments, by Region, 2019-2032 (USD Million)
  • 7.5. Software
    • 7.5.1. Global Rare Disease Diagnostics Market, by Software, by Region, 2019-2032 (USD Million)

8. Global Rare Disease Diagnostics Market, by Sample Type

  • 8.1. Key Findings
  • 8.2. Introduction
    • 8.2.1. Global Rare Disease Diagnostics Market, by Sample Type, 2019-2032 (USD Million)
  • 8.3. Blood Sample
    • 8.3.1. Global Rare Disease Diagnostics Market, by Blood Sample, by Region, 2019-2032 (USD Million)
  • 8.4. Buccal Swab Sample
    • 8.4.1. Global Rare Disease Diagnostics Market, by Buccal Swab Sample, by Region, 2019-2032 (USD Million)
  • 8.5. Others
    • 8.5.1. Global Rare Disease Diagnostics Market, by Others, by Region, 2019-2032 (USD Million)

9. Global Rare Disease Diagnostics Market, by Technology

  • 9.1. Key Findings
  • 9.2. Introduction
    • 9.2.1. Global Rare Disease Diagnostics Market, by Technology, 2019-2032 (USD Million)
  • 9.3. Next Generation Sequencing
    • 9.3.1. Global Rare Disease Diagnostics Market, by Next Generation Sequencing, by Region, 2019-2032 (USD Million)
  • 9.4. Whole Exome
    • 9.4.1. Global Rare Disease Diagnostics Market, by Whole Exome, by Region, 2019-2032 (USD Million)
  • 9.5. Whole Genome
    • 9.5.1. Global Rare Disease Diagnostics Market, by Whole Genome, by Region, 2019-2032 (USD Million)
  • 9.6. Array Technology
    • 9.6.1. Global Rare Disease Diagnostics Market, by Array Technology, by Region, 2019-2032 (USD Million)
  • 9.7. PCR Based Testing
    • 9.7.1. Global Rare Disease Diagnostics Market, by PCR Based Testing, by Region, 2019-2032 (USD Million)
  • 9.8. FISH
    • 9.8.1. Global Rare Disease Diagnostics Market, by FISH, by Region, 2019-2032 (USD Million)
  • 9.9. Sanger Sequencing
    • 9.9.1. Global Rare Disease Diagnostics Market, by Sanger Sequencing, by Region, 2019-2032 (USD Million)
  • 9.10. Karyotyping
    • 9.10.1. Global Rare Disease Diagnostics Market, by Karyotyping, by Region, 2019-2032 (USD Million)

10. Global Rare Disease Diagnostics Market, by Test

  • 10.1. Key Findings
  • 10.2. Introduction
    • 10.2.1. Global Rare Disease Diagnostics Market, by Test, 2019-2032 (USD Million)
  • 10.3. Genetic Test
    • 10.3.1. Global Rare Disease Diagnostics Market, by Genetic Test, by Region, 2019-2032 (USD Million)
  • 10.4. General Lab Test
    • 10.4.1. Global Rare Disease Diagnostics Market, by General Lab Test, by Region, 2019-2032 (USD Million)
  • 10.5. Imaging Test
    • 10.5.1. Global Rare Disease Diagnostics Market, by Imaging Test, by Region, 2019-2032 (USD Million)

11. Global Rare Disease Diagnostics Market, by Age Group

  • 11.1. Key Findings
  • 11.2. Introduction
    • 11.2.1. Global Rare Disease Diagnostics Market, by Age Group, 2019-2032 (USD Million)
  • 11.3. Adult
    • 11.3.1. Global Rare Disease Diagnostics Market, by Adult, by Region, 2019-2032 (USD Million)
  • 11.4. Children
    • 11.4.1. Global Rare Disease Diagnostics Market, by Children, by Region, 2019-2032 (USD Million)

12. Global Rare Disease Diagnostics Market, by Trait Type

  • 12.1. Key Findings
  • 12.2. Introduction
    • 12.2.1. Global Rare Disease Diagnostics Market, by Trait Type, 2019-2032 (USD Million)
  • 12.3. Inherited
    • 12.3.1. Global Rare Disease Diagnostics Market, by Inherited, by Region, 2019-2032 (USD Million)
  • 12.4. Acquired
    • 12.4.1. Global Rare Disease Diagnostics Market, by Acquired, by Region, 2019-2032 (USD Million)

13. Global Rare Disease Diagnostics Market, by End-Use

  • 13.1. Key Findings
  • 13.2. Introduction
    • 13.2.1. Global Rare Disease Diagnostics Market, by End-Use, 2019-2032 (USD Million)
  • 13.3. Research Laboratories & CROs
    • 13.3.1. Global Rare Disease Diagnostics Market, by Research Laboratories & CROs, by Region, 2019-2032 (USD Million)
  • 13.4. Hospitals & Clinics
    • 13.4.1. Global Rare Disease Diagnostics Market, by Hospitals & Clinics, by Region, 2019-2032 (USD Million)
  • 13.5. Diagnostic Laboratories
    • 13.5.1. Global Rare Disease Diagnostics Market, by Diagnostic Laboratories, by Region, 2019-2032 (USD Million)

14. Global Rare Disease Diagnostics Market, by Geography

  • 14.1. Key Findings
  • 14.2. Introduction
    • 14.2.1. Rare Disease Diagnostics Market Assessment, By Geography, 2019-2032 (USD Million)
  • 14.3. Rare Disease Diagnostics Market - North America
    • 14.3.1. North America: Rare Disease Diagnostics Market, by Disease Type, 2019-2032 (USD Million)
    • 14.3.2. North America: Rare Disease Diagnostics Market, by Technology, 2019-2032 (USD Million)
    • 14.3.3. North America: Rare Disease Diagnostics Market, by Mode of Product Type, 2019-2032 (USD Million)
    • 14.3.4. North America: Rare Disease Diagnostics Market, by Test, 2019-2032 (USD Million)
    • 14.3.5. North America: Rare Disease Diagnostics Market, by Sample Type, 2019-2032 (USD Million)
    • 14.3.6. North America: Rare Disease Diagnostics Market, by Age Group, 2019-2032 (USD Million)
    • 14.3.7. North America: Rare Disease Diagnostics Market, by Trait Type, 2019-2032 (USD Million)
    • 14.3.8. Rare Disease Diagnostics Market - U.S.
      • 14.3.8.1. U.S.: Rare Disease Diagnostics Market, by Disease Type, 2019-2032 (USD Million)
      • 14.3.8.2. U.S.: Rare Disease Diagnostics Market, by Technology, 2019-2032 (USD Million)
      • 14.3.8.3. U.S.: Rare Disease Diagnostics Market, by Mode of Product Type, 2019-2032 (USD Million)
      • 14.3.8.4. U.S.: Rare Disease Diagnostics Market, by Test, 2019-2032 (USD Million)
      • 14.3.8.5. U.S.: Rare Disease Diagnostics Market, by Sample Type, 2019-2032 (USD Million)
      • 14.3.8.6. U.S.: Rare Disease Diagnostics Market, by Age Group, 2019-2032 (USD Million)
      • 14.3.8.7. U.S.: Rare Disease Diagnostics Market, by Trait Type, 2019-2032 (USD Million)
    • 14.3.9. Rare Disease Diagnostics Market - Canada
      • 14.3.9.1. Canada: Rare Disease Diagnostics Market, by Disease Type, 2019-2032 (USD Million)
      • 14.3.9.2. Canada: Rare Disease Diagnostics Market, by Technology, 2019-2032 (USD Million)
      • 14.3.9.3. Canada: Rare Disease Diagnostics Market, by Mode of Product Type, 2019-2032 (USD Million)
      • 14.3.9.4. Canada: Rare Disease Diagnostics Market, by Test, 2019-2032 (USD Million)
      • 14.3.9.5. Canada: Rare Disease Diagnostics Market, by Sample Type, 2019-2032 (USD Million)
      • 14.3.9.6. Canada: Rare Disease Diagnostics Market, by Age Group, 2019-2032 (USD Million)
      • 14.3.9.7. Canada: Rare Disease Diagnostics Market, by Trait Type, 2019-2032 (USD Million)
  • 14.4. Rare Disease Diagnostics Market - Europe
    • 14.4.1. Europe: Rare Disease Diagnostics Market, by Disease Type, 2019-2032 (USD Million)
    • 14.4.2. Europe: Rare Disease Diagnostics Market, by Technology, 2019-2032 (USD Million)
    • 14.4.3. Europe: Rare Disease Diagnostics Market, by Mode of Product Type, 2019-2032 (USD Million)
    • 14.4.4. Europe: Rare Disease Diagnostics Market, by Test, 2019-2032 (USD Million)
    • 14.4.5. Europe: Rare Disease Diagnostics Market, by Sample Type, 2019-2032 (USD Million)
    • 14.4.6. Europe: Rare Disease Diagnostics Market, by Age Group, 2019-2032 (USD Million)
    • 14.4.7. Europe: Rare Disease Diagnostics Market, by Trait Type, 2019-2032 (USD Million)
    • 14.4.8. Rare Disease Diagnostics Market - UK
      • 14.4.8.1. UK: Rare Disease Diagnostics Market, by Disease Type, 2019-2032 (USD Million)
      • 14.4.8.2. UK: Rare Disease Diagnostics Market, by Technology, 2019-2032 (USD Million)
      • 14.4.8.3. UK: Rare Disease Diagnostics Market, by Mode of Product Type, 2019-2032 (USD Million)
      • 14.4.8.4. UK: Rare Disease Diagnostics Market, by Test, 2019-2032 (USD Million)
      • 14.4.8.5. UK: Rare Disease Diagnostics Market, by Sample Type, 2019-2032 (USD Million)
      • 14.4.8.6. UK: Rare Disease Diagnostics Market, by Age Group, 2019-2032 (USD Million)
      • 14.4.8.7. UK: Rare Disease Diagnostics Market, by Trait Type, 2019-2032 (USD Million)
    • 14.4.9. Rare Disease Diagnostics Market - France
      • 14.4.9.1. France: Rare Disease Diagnostics Market, by Disease Type, 2019-2032 (USD Million)
      • 14.4.9.2. France: Rare Disease Diagnostics Market, by Technology, 2019-2032 (USD Million)
      • 14.4.9.3. France: Rare Disease Diagnostics Market, by Mode of Product Type, 2019-2032 (USD Million)
      • 14.4.9.4. France: Rare Disease Diagnostics Market, by Test, 2019-2032 (USD Million)
      • 14.4.9.5. France: Rare Disease Diagnostics Market, by Sample Type, 2019-2032 (USD Million)
      • 14.4.9.6. France: Rare Disease Diagnostics Market, by Age Group, 2019-2032 (USD Million)
      • 14.4.9.7. France: Rare Disease Diagnostics Market, by Trait Type, 2019-2032 (USD Million)
    • 14.4.10. Rare Disease Diagnostics Market - Germany
      • 14.4.10.1. Germany: Rare Disease Diagnostics Market, by Disease Type, 2019-2032 (USD Million)
      • 14.4.10.2. Germany: Rare Disease Diagnostics Market, by Technology, 2019-2032 (USD Million)
      • 14.4.10.3. Germany: Rare Disease Diagnostics Market, by Mode of Product Type, 2019-2032 (USD Million)
      • 14.4.10.4. Germany: Rare Disease Diagnostics Market, by Test, 2019-2032 (USD Million)
      • 14.4.10.5. Germany: Rare Disease Diagnostics Market, by Sample Type, 2019-2032 (USD Million)
      • 14.4.10.6. Germany: Rare Disease Diagnostics Market, by Age Group, 2019-2032 (USD Million)
      • 14.4.10.7. Germany: Rare Disease Diagnostics Market, by Trait Type, 2019-2032 (USD Million)
    • 14.4.11. Rare Disease Diagnostics Market - Italy
      • 14.4.11.1. Italy: Rare Disease Diagnostics Market, by Disease Type, 2019-2032 (USD Million)
      • 14.4.11.2. Italy: Rare Disease Diagnostics Market, by Technology, 2019-2032 (USD Million)
      • 14.4.11.3. Italy: Rare Disease Diagnostics Market, by Mode of Product Type, 2019-2032 (USD Million)
      • 14.4.11.4. Italy: Rare Disease Diagnostics Market, by Test, 2019-2032 (USD Million)
      • 14.4.11.5. Italy: Rare Disease Diagnostics Market, by Sample Type, 2019-2032 (USD Million)
      • 14.4.11.6. Italy: Rare Disease Diagnostics Market, by Age Group, 2019-2032 (USD Million)
      • 14.4.11.7. Italy: Rare Disease Diagnostics Market, by Trait Type, 2019-2032 (USD Million)
    • 14.4.12. Rare Disease Diagnostics Market - Spain
      • 14.4.12.1. Spain: Rare Disease Diagnostics Market, by Disease Type, 2019-2032 (USD Million)
      • 14.4.12.2. Spain: Rare Disease Diagnostics Market, by Technology, 2019-2032 (USD Million)
      • 14.4.12.3. Spain: Rare Disease Diagnostics Market, by Mode of Product Type, 2019-2032 (USD Million)
      • 14.4.12.4. Spain: Rare Disease Diagnostics Market, by Test, 2019-2032 (USD Million)
      • 14.4.12.5. Spain: Rare Disease Diagnostics Market, by Sample Type, 2019-2032 (USD Million)
      • 14.4.12.6. Spain: Rare Disease Diagnostics Market, by Age Group, 2019-2032 (USD Million)
      • 14.4.12.7. Spain: Rare Disease Diagnostics Market, by Trait Type, 2019-2032 (USD Million)
    • 14.4.13. Rare Disease Diagnostics Market - Netherlands
      • 14.4.13.1. Netherlands: Rare Disease Diagnostics Market, by Disease Type, 2019-2032 (USD Million)
      • 14.4.13.2. Netherlands: Rare Disease Diagnostics Market, by Technology, 2019-2032 (USD Million)
      • 14.4.13.3. Netherlands: Rare Disease Diagnostics Market, by Mode of Product Type, 2019-2032 (USD Million)
      • 14.4.13.4. Netherlands: Rare Disease Diagnostics Market, by Test, 2019-2032 (USD Million)
      • 14.4.13.5. Netherlands: Rare Disease Diagnostics Market, by Sample Type, 2019-2032 (USD Million)
      • 14.4.13.6. Netherlands: Rare Disease Diagnostics Market, by Age Group, 2019-2032 (USD Million)
      • 14.4.13.7. Netherlands: Rare Disease Diagnostics Market, by Trait Type, 2019-2032 (USD Million)
    • 14.4.14. Rare Disease Diagnostics Market - Russia
      • 14.4.14.1. Russia: Rare Disease Diagnostics Market, by Disease Type, 2019-2032 (USD Million)
      • 14.4.14.2. Russia: Rare Disease Diagnostics Market, by Technology, 2019-2032 (USD Million)
      • 14.4.14.3. Russia: Rare Disease Diagnostics Market, by Mode of Product Type, 2019-2032 (USD Million)
      • 14.4.14.4. Russia: Rare Disease Diagnostics Market, by Test, 2019-2032 (USD Million)
      • 14.4.14.5. Russia: Rare Disease Diagnostics Market, by Sample Type, 2019-2032 (USD Million)
      • 14.4.14.6. Russia: Rare Disease Diagnostics Market, by Age Group, 2019-2032 (USD Million)
      • 14.4.14.7. Russia: Rare Disease Diagnostics Market, by Trait Type, 2019-2032 (USD Million)
  • 14.5. Rare Disease Diagnostics Market - Asia Pacific
    • 14.5.1. Asia Pacific: Rare Disease Diagnostics Market, by Disease Type, 2019-2032 (USD Million)
    • 14.5.2. Asia Pacific: Rare Disease Diagnostics Market, by Technology, 2019-2032 (USD Million)
    • 14.5.3. Asia Pacific: Rare Disease Diagnostics Market, by Mode of Product Type, 2019-2032 (USD Million)
    • 14.5.4. Asia Pacific: Rare Disease Diagnostics Market, by Test, 2019-2032 (USD Million)
    • 14.5.5. Asia Pacific: Rare Disease Diagnostics Market, by Sample Type, 2019-2032 (USD Million)
    • 14.5.6. Asia Pacific: Rare Disease Diagnostics Market, by Age Group, 2019-2032 (USD Million)
    • 14.5.7. Asia Pacific: Rare Disease Diagnostics Market, by Trait Type, 2019-2032 (USD Million)
    • 14.5.8. Rare Disease Diagnostics Market - China
      • 14.5.8.1. China: Rare Disease Diagnostics Market, by Disease Type, 2019-2032 (USD Million)
      • 14.5.8.2. China: Rare Disease Diagnostics Market, by Technology, 2019-2032 (USD Million)
      • 14.5.8.3. China: Rare Disease Diagnostics Market, by Mode of Product Type, 2019-2032 (USD Million)
      • 14.5.8.4. China: Rare Disease Diagnostics Market, by Test, 2019-2032 (USD Million)
      • 14.5.8.5. China: Rare Disease Diagnostics Market, by Sample Type, 2019-2032 (USD Million)
      • 14.5.8.6. China: Rare Disease Diagnostics Market, by Age Group, 2019-2032 (USD Million)
      • 14.5.8.7. China: Rare Disease Diagnostics Market, by Trait Type, 2019-2032 (USD Million)
    • 14.5.9. Rare Disease Diagnostics Market - India
      • 14.5.9.1. India: Rare Disease Diagnostics Market, by Disease Type, 2019-2032 (USD Million)
      • 14.5.9.2. India: Rare Disease Diagnostics Market, by Technology, 2019-2032 (USD Million)
      • 14.5.9.3. India: Rare Disease Diagnostics Market, by Mode of Product Type, 2019-2032 (USD Million)
      • 14.5.9.4. India: Rare Disease Diagnostics Market, by Test, 2019-2032 (USD Million)
      • 14.5.9.5. India: Rare Disease Diagnostics Market, by Sample Type, 2019-2032 (USD Million)
      • 14.5.9.6. India: Rare Disease Diagnostics Market, by Age Group, 2019-2032 (USD Million)
      • 14.5.9.7. India: Rare Disease Diagnostics Market, by Trait Type, 2019-2032 (USD Million)
    • 14.5.10. Rare Disease Diagnostics Market - Japan
      • 14.5.10.1. Japan: Rare Disease Diagnostics Market, by Disease Type, 2019-2032 (USD Million)
      • 14.5.10.2. Japan: Rare Disease Diagnostics Market, by Technology, 2019-2032 (USD Million)
      • 14.5.10.3. Japan: Rare Disease Diagnostics Market, by Mode of Product Type, 2019-2032 (USD Million)
      • 14.5.10.4. Japan: Rare Disease Diagnostics Market, by Test, 2019-2032 (USD Million)
      • 14.5.10.5. Japan: Rare Disease Diagnostics Market, by Sample Type, 2019-2032 (USD Million)
      • 14.5.10.6. Japan: Rare Disease Diagnostics Market, by Age Group, 2019-2032 (USD Million)
      • 14.5.10.7. Japan: Rare Disease Diagnostics Market, by Trait Type, 2019-2032 (USD Million)
    • 14.5.11. Rare Disease Diagnostics Market - Malaysia
      • 14.5.11.1. Malaysia: Rare Disease Diagnostics Market, by Disease Type, 2019-2032 (USD Million)
      • 14.5.11.2. Malaysia: Rare Disease Diagnostics Market, by Technology, 2019-2032 (USD Million)
      • 14.5.11.3. Malaysia: Rare Disease Diagnostics Market, by Mode of Product Type, 2019-2032 (USD Million)
      • 14.5.11.4. Malaysia: Rare Disease Diagnostics Market, by Test, 2019-2032 (USD Million)
      • 14.5.11.5. Malaysia: Rare Disease Diagnostics Market, by Sample Type, 2019-2032 (USD Million)
      • 14.5.11.6. Malaysia: Rare Disease Diagnostics Market, by Age Group, 2019-2032 (USD Million)
      • 14.5.11.7. Malaysia: Rare Disease Diagnostics Market, by Trait Type, 2019-2032 (USD Million)
    • 14.5.12. Rare Disease Diagnostics Market - Indonesia
      • 14.5.12.1. Indonesia: Rare Disease Diagnostics Market, by Disease Type, 2019-2032 (USD Million)
      • 14.5.12.2. Indonesia: Rare Disease Diagnostics Market, by Technology, 2019-2032 (USD Million)
      • 14.5.12.3. Indonesia: Rare Disease Diagnostics Market, by Mode of Product Type, 2019-2032 (USD Million)
      • 14.5.12.4. Indonesia: Rare Disease Diagnostics Market, by Test, 2019-2032 (USD Million)
      • 14.5.12.5. Indonesia: Rare Disease Diagnostics Market, by Sample Type, 2019-2032 (USD Million)
      • 14.5.12.6. Indonesia: Rare Disease Diagnostics Market, by Age Group, 2019-2032 (USD Million)
      • 14.5.12.7. Indonesia: Rare Disease Diagnostics Market, by Trait Type, 2019-2032 (USD Million)
    • 14.5.13. Rare Disease Diagnostics Market - South Korea
      • 14.5.13.1. South Korea: Rare Disease Diagnostics Market, by Disease Type, 2019-2032 (USD Million)
      • 14.5.13.2. South Korea: Rare Disease Diagnostics Market, by Technology, 2019-2032 (USD Million)
      • 14.5.13.3. South Korea: Rare Disease Diagnostics Market, by Mode of Product Type, 2019-2032 (USD Million)
      • 14.5.13.4. South Korea: Rare Disease Diagnostics Market, by Test, 2019-2032 (USD Million)
      • 14.5.13.5. South Korea: Rare Disease Diagnostics Market, by Sample Type, 2019-2032 (USD Million)
      • 14.5.13.6. South Korea: Rare Disease Diagnostics Market, by Age Group, 2019-2032 (USD Million)
      • 14.5.13.7. South Korea: Rare Disease Diagnostics Market, by Trait Type, 2019-2032 (USD Million)
  • 14.6. Rare Disease Diagnostics Market - Middle East & Africa
    • 14.6.1. Middle East & Africa: Rare Disease Diagnostics Market, by Disease Type, 2019-2032 (USD Million)
    • 14.6.2. Middle East & Africa: Rare Disease Diagnostics Market, by Technology, 2019-2032 (USD Million)
    • 14.6.3. Middle East & Africa: Rare Disease Diagnostics Market, by Mode of Product Type, 2019-2032 (USD Million)
    • 14.6.4. Middle East & Africa: Rare Disease Diagnostics Market, by Test, 2019-2032 (USD Million)
    • 14.6.5. Middle East & Africa: Rare Disease Diagnostics Market, by Sample Type, 2019-2032 (USD Million)
    • 14.6.6. Middle East & Africa: Rare Disease Diagnostics Market, by Age Group, 2019-2032 (USD Million)
    • 14.6.7. Middle East & Africa: Rare Disease Diagnostics Market, by Trait Type, 2019-2032 (USD Million)
    • 14.6.8. Rare Disease Diagnostics Market - Saudi Arabia
      • 14.6.8.1. Saudi Arabia: Rare Disease Diagnostics Market, by Disease Type, 2019-2032 (USD Million)
      • 14.6.8.2. Saudi Arabia: Rare Disease Diagnostics Market, by Technology, 2019-2032 (USD Million)
      • 14.6.8.3. Saudi Arabia: Rare Disease Diagnostics Market, by Mode of Product Type, 2019-2032 (USD Million)
      • 14.6.8.4. Saudi Arabia: Rare Disease Diagnostics Market, by Test, 2019-2032 (USD Million)
      • 14.6.8.5. Saudi Arabia: Rare Disease Diagnostics Market, by Sample Type, 2019-2032 (USD Million)
      • 14.6.8.6. Saudi Arabia: Rare Disease Diagnostics Market, by Age Group, 2019-2032 (USD Million)
      • 14.6.8.7. Saudi Arabia: Rare Disease Diagnostics Market, by Trait Type, 2019-2032 (USD Million)
    • 14.6.9. Rare Disease Diagnostics Market - UAE
      • 14.6.9.1. UAE: Rare Disease Diagnostics Market, by Disease Type, 2019-2032 (USD Million)
      • 14.6.9.2. UAE: Rare Disease Diagnostics Market, by Technology, 2019-2032 (USD Million)
      • 14.6.9.3. UAE: Rare Disease Diagnostics Market, by Mode of Product Type, 2019-2032 (USD Million)
      • 14.6.9.4. UAE: Rare Disease Diagnostics Market, by Test, 2019-2032 (USD Million)
      • 14.6.9.5. UAE: Rare Disease Diagnostics Market, by Sample Type, 2019-2032 (USD Million)
      • 14.6.9.6. UAE: Rare Disease Diagnostics Market, by Age Group, 2019-2032 (USD Million)
      • 14.6.9.7. UAE: Rare Disease Diagnostics Market, by Trait Type, 2019-2032 (USD Million)
    • 14.6.10. Rare Disease Diagnostics Market - Israel
      • 14.6.10.1. Israel: Rare Disease Diagnostics Market, by Disease Type, 2019-2032 (USD Million)
      • 14.6.10.2. Israel: Rare Disease Diagnostics Market, by Technology, 2019-2032 (USD Million)
      • 14.6.10.3. Israel: Rare Disease Diagnostics Market, by Mode of Product Type, 2019-2032 (USD Million)
      • 14.6.10.4. Israel: Rare Disease Diagnostics Market, by Test, 2019-2032 (USD Million)
      • 14.6.10.5. Israel: Rare Disease Diagnostics Market, by Sample Type, 2019-2032 (USD Million)
      • 14.6.10.6. Israel: Rare Disease Diagnostics Market, by Age Group, 2019-2032 (USD Million)
      • 14.6.10.7. Israel: Rare Disease Diagnostics Market, by Trait Type, 2019-2032 (USD Million)
    • 14.6.11. Rare Disease Diagnostics Market - South Africa
      • 14.6.11.1. South Africa: Rare Disease Diagnostics Market, by Disease Type, 2019-2032 (USD Million)
      • 14.6.11.2. South Africa: Rare Disease Diagnostics Market, by Technology, 2019-2032 (USD Million)
      • 14.6.11.3. South Africa: Rare Disease Diagnostics Market, by Mode of Product Type, 2019-2032 (USD Million)
      • 14.6.11.4. South Africa: Rare Disease Diagnostics Market, by Test, 2019-2032 (USD Million)
      • 14.6.11.5. South Africa: Rare Disease Diagnostics Market, by Sample Type, 2019-2032 (USD Million)
      • 14.6.11.6. South Africa: Rare Disease Diagnostics Market, by Age Group, 2019-2032 (USD Million)
      • 14.6.11.7. South Africa: Rare Disease Diagnostics Market, by Trait Type, 2019-2032 (USD Million)
  • 14.7. Rare Disease Diagnostics Market - Latin America
    • 14.7.1. Latin America: Rare Disease Diagnostics Market, by Disease Type, 2019-2032 (USD Million)
    • 14.7.2. Latin America: Rare Disease Diagnostics Market, by Technology, 2019-2032 (USD Million)
    • 14.7.3. Latin America: Rare Disease Diagnostics Market, by Mode of Product Type, 2019-2032 (USD Million)
    • 14.7.4. Latin America: Rare Disease Diagnostics Market, by Test, 2019-2032 (USD Million)
    • 14.7.5. Latin America: Rare Disease Diagnostics Market, by Sample Type, 2019-2032 (USD Million)
    • 14.7.6. Latin America: Rare Disease Diagnostics Market, by Age Group, 2019-2032 (USD Million)
    • 14.7.7. Latin America: Rare Disease Diagnostics Market, by Trait Type, 2019-2032 (USD Million)
    • 14.7.8. Rare Disease Diagnostics Market - Mexico
      • 14.7.8.1. Mexico: Rare Disease Diagnostics Market, by Disease Type, 2019-2032 (USD Million)
      • 14.7.8.2. Mexico: Rare Disease Diagnostics Market, by Technology, 2019-2032 (USD Million)
      • 14.7.8.3. Mexico: Rare Disease Diagnostics Market, by Mode of Product Type, 2019-2032 (USD Million)
      • 14.7.8.4. Mexico: Rare Disease Diagnostics Market, by Test, 2019-2032 (USD Million)
      • 14.7.8.5. Mexico: Rare Disease Diagnostics Market, by Sample Type, 2019-2032 (USD Million)
      • 14.7.8.6. Mexico: Rare Disease Diagnostics Market, by Age Group, 2019-2032 (USD Million)
      • 14.7.8.7. Mexico: Rare Disease Diagnostics Market, by Trait Type, 2019-2032 (USD Million)
    • 14.7.9. Rare Disease Diagnostics Market - Brazil
      • 14.7.9.1. Brazil: Rare Disease Diagnostics Market, by Disease Type, 2019-2032 (USD Million)
      • 14.7.9.2. Brazil: Rare Disease Diagnostics Market, by Technology, 2019-2032 (USD Million)
      • 14.7.9.3. Brazil: Rare Disease Diagnostics Market, by Mode of Product Type, 2019-2032 (USD Million)
      • 14.7.9.4. Brazil: Rare Disease Diagnostics Market, by Test, 2019-2032 (USD Million)
      • 14.7.9.5. Brazil: Rare Disease Diagnostics Market, by Sample Type, 2019-2032 (USD Million)
      • 14.7.9.6. Brazil: Rare Disease Diagnostics Market, by Age Group, 2019-2032 (USD Million)
      • 14.7.9.7. Brazil: Rare Disease Diagnostics Market, by Trait Type, 2019-2032 (USD Million)
    • 14.7.10. Rare Disease Diagnostics Market - Argentina
      • 14.7.10.1. Argentina: Rare Disease Diagnostics Market, by Disease Type, 2019-2032 (USD Million)
      • 14.7.10.2. Argentina: Rare Disease Diagnostics Market, by Technology, 2019-2032 (USD Million)
      • 14.7.10.3. Argentina: Rare Disease Diagnostics Market, by Mode of Product Type, 2019-2032 (USD Million)
      • 14.7.10.4. Argentina: Rare Disease Diagnostics Market, by Test, 2019-2032 (USD Million)
      • 14.7.10.5. Argentina: Rare Disease Diagnostics Market, by Sample Type, 2019-2032 (USD Million)
      • 14.7.10.6. Argentina: Rare Disease Diagnostics Market, by Age Group, 2019-2032 (USD Million)
      • 14.7.10.7. Argentina: Rare Disease Diagnostics Market, by Trait Type, 2019-2032 (USD Million)

15. Competitive Landscape

  • 15.1. Expansion and Acquisition Analysis
    • 15.1.1. Expansion
    • 15.1.2. Acquisitions
  • 15.2. Partnerships/Collaborations/Agreements/Exhibitions

16. Company Profiles

  • 16.1. 3billion, Inc.
    • 16.1.1. Company Overview
    • 16.1.2. Financial Performance
    • 16.1.3. Product Benchmarking
    • 16.1.4. Recent Development
  • 16.2. Agilent Technologies, Inc
    • 16.2.1. Company Overview
    • 16.2.2. Financial Performance
    • 16.2.3. Product Benchmarking
    • 16.2.4. Recent Development
  • 16.3. CENTOGENE N.V
    • 16.3.1. Company Overview
    • 16.3.2. Financial Performance
    • 16.3.3. Product Benchmarking
    • 16.3.4. Recent Development
  • 16.4. F. Hoffmann-La Roche Ltd
    • 16.4.1. Company Overview
    • 16.4.2. Financial Performance
    • 16.4.3. Product Benchmarking
    • 16.4.4. Recent Development
  • 16.5. FDNA(TM) INC
    • 16.5.1. Company Overview
    • 16.5.2. Financial Performance
    • 16.5.3. Product Benchmarking
    • 16.5.4. Recent Development
  • 16.6. GeneDx, LLC
    • 16.6.1. Company Overview
    • 16.6.2. Financial Performance
    • 16.6.3. Product Benchmarking
    • 16.6.4. Recent Development
  • 16.7. Illumina, Inc.
    • 16.7.1. Company Overview
    • 16.7.2. Financial Performance
    • 16.7.3. Product Benchmarking
    • 16.7.4. Recent Development
  • 16.8. Invitae Corporation
    • 16.8.1. Company Overview
    • 16.8.2. Financial Performance
    • 16.8.3. Product Benchmarking
    • 16.8.4. Recent Development
  • 16.9. Novo Nordisk A/S
    • 16.9.1. Company Overview
    • 16.9.2. Financial Performance
    • 16.9.3. Product Benchmarking
    • 16.9.4. Recent Development
  • 16.10. Quest Diagnostics
    • 16.10.1. Company Overview
    • 16.10.2. Financial Performance
    • 16.10.3. Product Benchmarking
    • 16.10.4. Recent Development